Involvement of oxidative and nitrosative stress in modulation of gene expression and functional responses by IFNγ

International Immunology

Volumn 19, Issue 7, 2007, Pages 867-879

  Prasanna, S Jyothi ^a   Saha, Banishree ^a   Nandi, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Cytokine; Growth suppression; Inflammation; Redox; Transcriptional profiling

Indexed keywords

B7 ANTIGEN; CATALASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPHENYLIODONIUM SALT; GAMMA INTERFERON; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN GAMMA; INDUCIBLE COSTIMULATOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITOR OF DIFFERENTIATION 2; LIM MINERALIZATION PROTEIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; N MYC DOWNSTREAM REGULATOR 1; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEASOME; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN SERINE KINASE; RAS PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRANSCRIPTION FACTOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEPATOMA CELL; IMMUNOMODULATION; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, SURFACE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; MICE; NITROSATION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 34547821979     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm058     Document Type: Article

References (70)

1. Dorman, S. E. and Holland, S. M. 2000. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 11:321.
2. Boehm, U., Klamp, T., Groot, M. and Howard, J. C. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
3. Schroder, K., Hertzog, P. J., Ravasi, T. and Hume, D. A. 2004. Interferon-γ: An overview of signals, mechanisms and function. J. Leukoc. Biol. 75:163.
4. Platanias, L. C. 2005. Mechanisms of type-I- and type-IIinterferon-mediated signalling. Nat. Rev. Immunol. 5:375.
5. Wen, Z., Zhong, Z. and Darnell, J. E. Jr 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241.
6. Zhu, M., John, S., Berg, M. and Leonard, W. J. 1999. Functional association of Nmi with Stat5 and Stat1 in IL-2 and IFNγ-mediated signaling. Cell 96:121.
7. Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A. and Horvath, C. M. 2000. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-γ target genes. Proc. Natl Acad. Sci. USA 97:5208.
8. Hiroi, M. and Ohmori, Y. 2003. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene. J. Biol. Chem. 278:651.
9. Der, S. D., Zhou, A., Williams, B. R. and Silverman, R. H. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95: 15623.
10. de Veer, M. J., Holko, M., Frevel, M. et al. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912.
11. Ehrt, S., Schnappinger, D., Bekiranov, S. et al. 2001. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123.
12. Patrone, L., Damore, M. A., Lee, M. B., Malone, C. S. and Wall, R. 2002. Genes expressed during the IFN gamma induced maturation of pre-B cells. Mol. Immunol. 38:597.
13. Kota, R. S., Rutledge, J. C., Gohil, K., Kumar, A., Enelow, R. I. and Ramana, C. V. 2006. Regulation of gene expression in RAW 264.7 macrophage cell line by interferon-gamma. Biochem. Biophys. Res. Commun. 342:1137.
14. Ramana, C. V., Gil, M. P., Han, Y., Ransohoff, R. M., Schreiber, R. D. and Stark, G. R. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl Acad. Sci. USA 98: 6674.
15. Sizemore, N., Agarwal, A., Das, K. et al. 2004. Inhibitor of κB kinase is required to activate a subset of interferon γ-stimulated genes. Proc. Natl Acad. Sci. USA 101:7994.
16. Harvat, B. L. and Jetten, A. M. 1996. γ-Interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ. 7:289.
17. Kominsky, S., Johnson, H. M., Bryan, G. et al. 1998. IFNγ inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1. Oncogene 17:2973.
18. Mandal, M., Bandyopadhyay, D., Goepfert, T. M. and Kumar, R. 1998. Interferon-induces expression of cyclin dependent kinaseinhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Oncogene 16:217.
19. Hobeika, A. C., Etienne, W., Torres, B. A., Johnson, H. M. and Subramaniam, P. 1999. IFN-γ induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. J. Interferon Cytokine Res. 19:1351.
20. Lee, S. H., Kim, J. W., Lee, H. W. et al. 2003. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene 22:381.
21. + T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:123.
22. Kaplan, D. H., Shankaran, V., Dighe, A. S. et al. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl Acad. Sci. USA 95:7556.
23. Shankaran, V., Ikeda, H., Bruce, A. T. et al. 2001. IFNγ and lymphocytes prevent primary tumour development and shape tumor immunogenicity. Nature 410:1107.
24. Street, S. E., Trapani, J. A., MacGregor, D. and Smyth, M. J. 2002. Suppression of lymphoma and epithelial malignancies effected by interferon γ. J. Exp. Med. 196:129.
25. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A. and Stewart, T. A. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
26. Dighe, A. S., Richards, E., Old, L. J. and Schreiber, R. D. 1994. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN γ receptors. Immunity 1:447.
27. 2-microglobulin. Mol. Immunol. 41:1029.
28. Rosenkranz, A. R., Schmaldienst, S., Stuhlmeier, K. M., Chen, W., Knapp, W. and Zlabinger, G. J. 1992. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescindiacetate. J. Immunol. Methods 156:39.
29. Mayo, L. A. and Curnette, J. T. 1990. Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells. Methods Enzymol. 186:567.
30. Palicz, A., Foubert, T. R., Jesaitis, A. J., Marodi, L. and Mc Phail, L. C. 2001. Phosphatidic acid and diacylglycerol directly activates NADPH-oxidase by interacting with enzyme components. J. Biol. Chem. 276:3090.
31. Chuang, S. M., Wang, I. C., Hwua, Y. S. and Yang, J. L. 2003. Short-term depletion of catalase suppresses cadmium-elicited c-Jun N-terminal kinase activation and apoptosis: Role of protein phosphatases. Carcinogenesis 24:7.
32. Malu, S., Srinivasan, S., Kumar, M. P., Rajagopal, D., John, B. and Nandi, D. 2003. IFN-gamma bioassay: Development of a sensitive method by measuring nitric oxide production by peritoneal exudate cells from C57BL/ 6 mice. J. Immunol. Methods 272:55.
33. Krishan, A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol. 66:188.
34. Azam, N., Vairapandi, M., Zhang, W., Hoffman, B. and Liebermann, D. A. 2000. Interaction of CR6 (GADD45γ) with proliferating cell nuclear antigen (PCNA) impedes negative growth control. J. Biol. Chem. 276:2766.
35. Piquemal, D., Joulia, D., Balaguer, P., Basset, A., Marti, J. and Commes, T. 1999. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim. Biophys. Acta 1450:364.
36. Lasorella, A., Iavarone, A. and Israel, M. A. 1996. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. Biol. 16:2570.
37. Brune, B. 2005. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid. Redox Signal. 7:497.
38. + Tcells integrate signalstrength information to modulate activation with Concanavalin A. J. Leukoc. Biol. 78:144.
39. Bogdan, C., Rollinghoff, M. and Diefenbach, A. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64.
40. Geiszt, M. and Leto, T. L. 2004. The Nox family of NADPH oxidases: Host defense and beyond. J. Biol. Chem. 279:51715.
41. Gurgul, E., Lortz, S., Tiedge, M., Jorns, A. and Lenzen, S. 2004. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 53:2271.
42. Irani, K., Xia, Y., Zweier, J. L. et al. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275:1649.
43. Nagase, T., Kawata, S., Tamura, S. et al. 1997. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells. Br. J. Cancer 76:1001.
44. Lee, A. C., Fenster, B. E., Ito, H. et al. 1999. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274:7936.
45. Svegliati, S., Cancello, R., Sambo, P. et al. 2005. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J. Biol. Chem. 280:36474.
46. Seru, R., Mondola, P., Damiano, S. et al. 2004. HaRas activates the NADPH oxidase complex in human neuroblastoma cells via the extracellular signal-regulated kinase 1/2 pathway. J. Neurochem. 91:613.
47. Watanabe, Y., Suzuki, O., Haruyama, T. and Akaike, T. 2003. Interferon-γ induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J. Cell. Biochem. 89:244.
48. Weisz, A., Cicatiello, L. and Esumi, H. 1996. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-γ, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Biochem. J. 316:209.
49. Chang, K., Lee, S. J., Cheong, I. et al. 2004. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IκB. Exp. Mol. Med. 36:311.
50. Lee, B. S., Kim, Y. M., Kang, H. S., Kim, H. M., Pyun, K. H. and Choi, I. 2001. Octamer binding protein-1 is involved in inhibition of inducible nitric oxide synthase expression by exogenous nitric oxide in murine liver cells. J. Biochem. 129:77.
51. Mendes, A. F., Carvalho, A. P., Caramona, M. M. and Lopes, M. C. 2001. Diphenyleneiodonium inhibits NFkappaB activation and iNOS expression induced by IL-1β: Involvement of reactive oxygen species. Mediators Inflamm. 10:209.
52. Pawate, S., Shen, Q., Fan, F. and Bhat, N. R. 2004. Redox regulation of glial inflammatory response to lipopolysaccharide and interferon γ. J. Neurosci. Res. 77:540.
53. Miralles, C., Busquets, X., Santos, C. et al. 2000. Regulation of iNOS expression and glutathione levels in rat liver by oxygen tension. FEBS Lett. 476:253.
54. Brennan, R. E., Russell, K., Zhang, G. and Samuel, J. E. 2004. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect. Immun. 72:6666.
55. Li, J., Baud, O., Vartanian, T., Volpe, J. J. and Rosenberg, P. A. 2005. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl Acad. Sci. USA 102:9936.
56. Pahan, K., Liu, X., McKinney, M. J., Wood, C., Sheikh, F. G. and Raymond, J. R. 2000. Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes. J. Neurochem. 74:2288.
57. Na, H. J., Lee, S. J., Kang, Y. C. et al. 2004. Inhibition of farnesyltransferase prevents collagen-induced arthritis by downregulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation. J. Immunol. 173:1276.
58. Nishiya, T., Uehara, T., Edamatsu, H., Kaziro, Y., Itoh, H. and Nomura, Y. 1997. Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-gamma-induced MAPK activation that is mediated by p21ras. FEBS Lett. 408:33.
59. Llovera, M., Pearson, J. D., Moreno, C. and Riveros-Moreno, V. 2001. Impaired response to interferon-γ in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Br. J. Pharmacol. 132:419.
60. Kamata, H. and Hirata, H. 1999. Redox regulation of cellular signalling. Cell. Signal. 11:1.
61. Song, J. H., So, E. Y. and Lee, C. E. 2002. Increased serine phosphorylation and activation of STAT1 by oncogenic Ras transfection. Mol. Cells 13:322.
62. Klampfer, L., Huang, J., Corner, G. et al. 2003. Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. J. Biol. Chem. 278:46278.
63. Seliger, B., Harders, C., Lohmann, S. et al. 1998. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts. Eur. J. Immunol. 28:122.
64. Pacelli, R., Wink, D. A., Cook, J. A. et al. 1995. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 182:1469.
65. Shiloh, M. U., MacMicking, J. D., Nicholson, S. et al. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10:29.
66. Lindgren, H., Stenman, L., Tarnvik, A. and Sjostedt, A. 2005. The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages. Microbes Infect. 7:467.
67. Gantt, K. R., Goldman, T. L., McCormick, M. L. et al. 2001. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167:893.
68. Eriksson, S., Chambers, B. J. and Rhen, M. 2003. Nitric oxide produced by murine dendritic cells is cytotoxic for intracellular Salmonella enterica sv. typhimurium. Scand. J. Immunol. 58:493.
69. Leiro, J., Alvarez, E., Arranz, J. A., Laguna, R., Uriarte, E. and Orallo, F. 2004. Effects of cis-resveratrol on inflammatory murine macrophages: Antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 75:1156.
70. Zhang, H. J., Doctrow, S. R., Xu, L. et al. 2004. Redox modulation of the liver with chronic antioxidant enzyme mimetic treatment prevents age related oxidative damage associated with environmental stress. FASEB J. 18:1547.